About
Bing Lim, MD, PhD is a biotech scientist and executive focused on thymic cell engineering, immune function, and aging-related biology. He is listed as Chief Scientific Officer of Thymmune Therapeutics, which is developing thymus-based regenerative therapies. Academic sources also associate him with Cancer Stem Cell Biology at the Genome Institute of Singapore and show that researchers such as Yvonne Tay began their careers in his lab.
Areas of interest
biotechimmunologystem cellsthymus biologyagingregenerative medicinecancer biology